Ticker LaunchIPO · SNDL
SNDL Inc.
Formerly Sundial Growers Inc.
SNDL Inc. (SNDL) priced its initial public offering on Aug 1, 2019 at $13.00 per share, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.09B. Torys and A&O Shearman advised the company and Osler advised the underwriters.
SNDL Inc. builds cannabis consumer brands under its Sundial name, organized around three areas: Heal for prescription cannabis medicine, Help for CBD products aimed at health and wellness, and Play for social and recreational use. It plans to pursue these globally as regulations allow.
- Status
- IPO
- Ticker
- SNDL
- Exchange
- Nasdaq Global Select
- Priced
- Aug 1, 2019
- IPO price
- $13.00
- Market cap at IPO price
- $1.09B
- First filed
- Jul 5, 2019
- Company counsel
- Torys and A&O Shearman
- Underwriters' counsel
- Osler
- Sector
- Biotech & pharma
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Jul 5, 2019
- Latest amendment Jul 30, 2019
- Final prospectus (424B4) Aug 1, 2019
- All filings on EDGAR CIK 1766600
Other Biotech & pharma IPOs in 2019
- Genmab A/SGMAB · Jul 19, 2019 · $505.9M
- Fulcrum Therapeutics, Inc.FULC · Jul 18, 2019 · $72M
- Mirum Pharmaceuticals, Inc.MIRM · Jul 18, 2019 · $75M
- BridgeBio Pharma, Inc.BBIO · Jun 28, 2019 · $348.5M
- Karuna Therapeutics, Inc.KRTX · Jun 28, 2019 · $89.2M
- Adaptive Biotechnologies CorpADPT · Jun 27, 2019 · $300M